---
title: Aluris Sciences vs JYMed Peptide
slug_a: aluris-sciences
slug_b: jymedtech
site: cdmo
review_signal_gate: closed
canonical_path: /compare/aluris-sciences/jymedtech
---

# Aluris Sciences vs JYMed Peptide

Side-by-side profile data from each company listing on this directory.

## Aluris Sciences

- Profile: [/companies/aluris-sciences](/companies/aluris-sciences)

Aluris Sciences — US-based CDMO specializing in complex life science, in vitro diagnostic, drug-device combination products, lyophilized formulations, and reagent manufacturing with 45 years of industry experience and 200+ life science partners.

Services: 8. Modalities: 0. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (8).

### Services

- Sterile Fill-Finish & Aseptic Manufacturing
- Lyophilization (Freeze Drying)
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Secondary Packaging & Labeling
- Combination Product Assembly & Final Packaging

### Modalities

- Data not yet provided.

### Development capabilities

- Analytical method development
- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)

## JYMed Peptide

- Profile: [/companies/jymedtech](/companies/jymedtech)

JYMed Peptide — Peptide CDMO offering custom synthesis from milligrams to metric tons, with 13 cGMP lines and FDA-, NMPA- and EDQM-approved sites. Provides peptide API manufacturing plus syringe, cartridge and lyophilized finished-dose filling at its Shenzhen site.

Services: 12. Modalities: 1. Indications: 0. Locations: 4. Certifications: 0. The strongest documented coverage currently appears in services (12).

### Services

- API Synthesis & Manufacturing
- Peptide Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Prefilled Syringe (PFS) Filling
- Cartridge Filling
- Lyophilization (Freeze Drying)
- Process Development
- Formulation Development
- CMC Analytical Development
- Quality Control Testing
- Secondary Packaging & Labeling
- CMC Regulatory Submission Support

### Modalities

- Peptide

### Development capabilities

- Analytical method development
- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Prefilled Syringes (PFS)
- Cartridges
- Max chemical: Commercial (>100 kg / tonne)
- HPAPI